{"id":"W4281670642","doi":"10.1200/jco.2022.40.16_suppl.9016","title":"Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met–overexpressing (OE) advanced non-small cell lung cancer (NSCLC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Immunohistochemistry; Cohort; Interim analysis; Oncology; Stage (stratigraphy); Clinical endpoint; Cancer; Lung cancer; Interim; Chemotherapy; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002801848,0.0002919969,0.0005324721,0.0001709473,0.0001573548,0.0004180191,0.0002137571,0.0003437593,0.001930946],"category_scores_gemma":[0.0002941352,0.00016546,0.0003722188,0.0002099648,0.0001734527,0.0003206912,0.0001595735,0.000731686,0.000441247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004942048,"about_ca_system_score_gemma":0.0005147321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006659974,"about_ca_topic_score_gemma":0.003452952,"domain_scores_codex":[0.9999094,0.00002535903,0.000006458753,0.00001754269,0.00001108501,0.00003013034],"domain_scores_gemma":[0.99986,0.00002216094,0.00003026391,0.000005330315,0.000006381048,0.00007568009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4176858,0.01399264,0.1075203,0.001297653,0.001360168,0.001543268,0.0005322654,0.00536274,0.07380335,0.0007110608,0.01073667,0.3654542],"study_design_scores_gemma":[0.1869672,0.4432103,0.3279085,0.000245324,0.001378092,0.002852366,0.0003178606,0.005708873,0.009736422,0.0006779914,0.02093351,0.00006347949],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953241,0.001557015,0.0001991697,0.000163603,0.00003665561,0.0003336403,0.0004793112,0.0000235059,0.001883115],"genre_scores_gemma":[0.997102,0.0006793217,0.000232338,0.0001924392,0.00003294888,0.0002185736,0.0006501638,0.00000371959,0.0008886575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001930946,"threshold_uncertainty_score":0.006459653,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03010467439627324,"score_gpt":0.4231097895866135,"score_spread":0.3930051151903403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}